Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10372 |
| Vaccine Name | Sf21-VLP (PXVX0317) |
| Disease Name | Chikungunya fever |
| Disease Classification | Exanthous |
| Virus Name | Chikungunya virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Virus like particle |
| Vaccine Status | Phase 3 |
| Manufacturer | Emergent BioSolutions |
| Year of Manufacturing | 2021 |
| Manufacturing Country | NA |
| Age | 12 - 65 years |
| Dosage | NA |
| Administration Route | NA |
| Adjuvant | Alhydrogel |
| Target Strain | NA |
| Description | Virus-like particle made using baculovirus and Sf21 insect cells |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT05072080 |
| Reference Link | https://link.springer.com/chapter/10.1007/82_2019_175 |
| Additional Links | https://clinicaltrials.gov/ct2/show/NCT05072080 |